News & Events
CEG All-Member Meeting: Thursday August 5, 2021, from 1:00 - 2:30 PM. CEG members, please plan to join us as we plan for our November 2, 2021 Precision Health Community Forum with NIEHS. We'll also discuss 2022 Pilot Project awards and plans for the Center's competitive renewal submission. Meeting location and online link TBA.
Save the New Date: Tuesday November 16, 2021: CEG-hosted
NIEHS Precision Health Community Forum. We look forward to welcoming to Cincinnati NIEHS Director Roy Woychik, PhD, and colleagues. Plans include scientific presentations from diverse avenues of research, a tour of regional
"toxic sites"\sites of environmental concern, and dialogue with local government and public health and community leaders. More details to come!
Yolton, Cecil, Ryan Team earns $5 million NIEHS R01 Award
CEG Internal Advisory Board member Kimberly Yolton, PhD, Professor and Director of Research Section, General and Community Pediatrics, Cincinnati Children’s Hospital Medical Center, and fellow CEG members Patrick H. Ryan, PhD, MS, Professor of Pediatrics, and Kim Cecil, PhD, Professor in the Department of Radiology, have received a new 5-year NIEHS R01 award: Longitudinal Impact of Air Pollution on Mental Health and Neuroimaging Outcomes during Adolescence in the Cincinnati Combined Childhood Cohorts (C4). R01 ES031621. Co-PI Patrick H. Ryan, PhD, MS, Professor of Pediatrics, and co-investigator Kim Cecil, PhD, are also CEG members. Project start-end 3/3/2021–12/31/2025, total 2021 funding $1.1 million.
The team will use existing longitudinal data from the Cincinnati Childhood Allergy and Air Pollution Study (CCAAPS) and the Health Outcomes and Measures of the Environment (HOME) Study to address the hypothesis that exposure to air pollution during critical periods of brain development, including adolescence, is associated with adverse mental health outcomes.
Both prospective cohorts have been followed from birth and evaluated with concordant measures of mental health and neuroimaging at age 12 years. The team will conduct new follow-up at age 18 years to assess the onset and persistence of mental health outcomes through adolescence and apply validated models for PM2.5 and TRAP to characterize air pollution exposure from conception through age 18 years. The team also will acquire novel neuroimaging outcomes, including brain-aminobutyric acid and glutathione concentrations accompanied by anatomical and functional magnetic resonance imaging.
The team aims to determine (1) the association between exposure to PM2.5 and TRAP during distinct developmental periods and the onset and persistence of mental health outcomes in adolescence; (2) the association between exposure to PM2.5 and TRAP
during distinct developmental periods and neuroimaging outcomes in late adolescence; and (3) whether changes in brain volume, organization, metabolism, and function mediate associations between PM2.5 and TRAP exposure and mental health outcomes.
The CEG welcomes our newest members:
Michael T. Williams, Ph.D., Associate Professor, UC Department of Pediatrics, Division of Neurology and Co-Director, Animal Behavior Core (CCHMC). Dr. Willams is interested in the study of developmental impacts, including genetic, environmental, and stress-related factors, on cognitive ability and behavioral sequelae throughout the lifetime. He has particular interest in the developmental impacts of exposure to manganese. He is a multi-PI with Dr. Charles (Chip) Vorhees on NIEHS R01 ES032270, “Gene-pesticide interactions and ADHD” (8/2020– 2/2025) and serves as Associate Director on NIH T32 ES07051 (PI: Vorhees) Training Grant in Teratology. CEG Full member.
Senu Apewokin, M.D., Associate Professor, UC College of Medicine Department of Internal Medicine, Divisiion of Infectious Diseases.Diseases. Dr. Apewokin's research interests are in the efficacy of vaccinations and in infectious disease in transplant patients. In 2019, he received a CEG New to EHS Pilot award, “Association between PFOA Exposure and Humoral Responses to Pneumococcal Vaccines” (25K). He also has a K08 award from the National Cancer Institute, 06/01/20 – 5/31/2025, “Harnessing induced human intestinal organoids (IHIOS) and metagenomics to unravel host immune-microbiota interactions during cancer chemotherapy-associated clostridium difficile infections.” CEG Clinical member.
Nalinikanth Kotagiri, Ph.D., MBBS, Assistant Professor, UC College of Pharmacy. Dr. Nalinikanth's research interests are primarily in therapeutic agents, but recently Dr. Kotagiri was awarded a $484,000 DoD grant to protect skin from ultraviolet light: MRP Idea Award:,“Engineering skin microbiome to generate natural sunscreens for prevention of melanoma” (Role PI. 7/1/21 – 6/30/24). CEG Associate member.
Dr. John Reichard, Ph.D.,
Assistant Professor in the Division of Industrial Hygiene in the UC Department of Environmental and Public Health Science. His research interests include applied human toxicology and chemical risk analysis, and he brings to the CEG highly respected
expertise in mechanistic toxicology, pharmacology, risk assessment and computational exposure modeling. He is currently collaborating with CEG members Susan Pinney, Ph.D., F.A.C.E. and Changchun Xie, Ph.D. on Dr. Pinney's R24 award from the National
Institute of Environmental Health Sciences, Fernald Community Cohort: Research Resource for Environmental Epidemiology (R24 ES028527). CEG Associate member.
Edward J. Merino, Ph.D., Associate Professor of Chemistry in the UC College of Arts and Sciences and a chemist with research interests at the juncture
between chemistry and biology. Dr. Merino has been part of research teams that develop molecules to selectively kill cancer cells that have reactive oxygen species, generate new sunscreens to prevent DNA damage, and projects wherein he serves
as the chemistry lead to develop new bioactive molecules. A particular interest is molecular design toward new technology, especially through reactivity. He is currently collaborating with Dr. Anna Luisa Kadekaro, a former CEG Career Development
Awardee, on an NIEHS R15 award, Limiting UV-induced genome instability with self-cycling antioxidant reagents (R15 ES029675). CEG Full member.
William Miller, Ph.D.,
Professor of Molecular Genetics and Director of the Molecular Genetics Graduate Program in the UC College of Medicine.The Miller laboratory is interested in the mechanisms by which microbial pathogens manipulate host cell signal transduction
pathways. Our main focus is on using cytomegaloviruses as model systems to examine how pathogens alter G-protein coupled receptor (GPCR) signaling pathways. Dr. Miller is director of the NIEHS-funded Environmental Carcinogeneses and Mutagenesis
T32 Training Program at the University of Cincinnati (T32 ES007250). Co-Leader: CEG Associate Director Alvaro Puga, Ph.D. CEG Full member.
* * *
Michelle Burbage, Ph.D., Assistant Professor of Public Health Sciences, has been named co-leader of the CEG Community Engagement Core (CEC). Dr. Burbage will work alongside CEC Director Nicholas Newman, D.O., M.S., and Program Manager Angela Larck, MSOL, to advance community-based participatory research and the translation of scientific knowledge among grassroots partners. Dr. Burbage has worked on projects with the Ronald McDonald House, Urban Appalachian Council, YWCA’s mammogram outreach program, and local schools and health departments. In 2018 Burbage received the prestigious Mirzayan Science & Technology Policy Fellowship of the National Academies of Sciences, Engineering, and Medicine. The Community Engagement Core provides fosters bi-directional communication between population and bench scientists specializing in the study of gene-environment interactions and stakeholders throughout our region.
* * *
Endocrine Disrupting Chemicals Research Focus Group meets on the 2nd Thursday of each month. All are welcome. For details please contact Katherine Burns, PhD, Assistant Professor, Department of Environmental and Public Health Sciences. For details about the CEG's ImmunoToxicology Forum contact Jagjit Yadav, PhD. For details about the Smoking-related Cancers Research Focus Group contact Scott Langevin, MHA, PhD. All are welcome.
* * *
The Application Submission System & Interface for Submission Tracking (ASSIST) system is used to submit applications electronically to NIEHS and other NIH and Public Health Service agencies. It is also used to ensure PIs' compliance with timely reporting of Human Subjects Study inclusion enrollment data, etc. Delays and errors in Human Subjects reporting via ASSIST can delay or jeopardize individual and Center funding; hence, this guidance on Navigating ASSIST for Human Subjects and Clinical Trials, presented by NIEHS staff specialist Martha Barnes, M.S. is important for PIs and their staff: PPT slides accessible here (PDF). Webinar recording accessible here (mp4 file).